Improving access and support for people with type 2 diabetes commencing injectable therapy

No Thumbnail Available
File version
Author(s)
Ogrin, R
Aylen, T
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2016
Size
File type(s)
Location
License
Abstract

In Australia over one million people have type 2 diabetes (NDSS, 2015), many aged 65 years or older (65 years > 43%; 75 years > 18.4%) (AIHW, 2012). A quarter of people with type 2 diabetes in Australia have an HbA1c >8% (Maclsaac et al. 2009), whereas the optimum range is <7% (UKPDS, 1998). Allowing for some who may need a higher HbA1c targets due to frailty or other health considerations, there are still many Australians with sub-optimal HbA1c levels likely to benefit from more intensive diabetes management.

Journal Title

Australian nursing & midwifery journal

Conference Title
Book Title
Edition
Volume

23

Issue

9

Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Nursing

Persistent link to this record
Citation

Ogrin, R; Aylen, T, Improving access and support for people with type 2 diabetes commencing injectable therapy, Australian nursing & midwifery journal, 2016, 23 (9), pp. 44-44

Collections